Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 230 is a nuclear protein predicted to function as a DNA-binding transcription factor, playing a role in the regulation of gene expression in humans. It contains zinc finger motifs that facilitate binding to DNA and may be involved in the control of DNA-templated transcription. There is no current evidence linking ZNF230 directly to therapeutic intervention, known disease mechanisms, or drug interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 230 (ZNF230).